Time to viral suppression is not related to achievement of Svr12 in Hcv Gt1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin

S. Alqahtani, R. Ozaras, V. Isakov, D. Wyles, P. Ferenci, J. J. Feld, F. Calinas, M. Gschwantler, E. Gane, D. Crawford, I. M. Jacobson, E. O. Dumas, M. King, M. Sulkowski

doi:10.1111/jvh.12641

DOI: 10.1111/jvh.12641

,

PMID: 27935166

Issn Print: 1352-0504

Publication Date: 2017/04/01

Print

S. Alqahtani; R. Ozaras; V. Isakov; D. Wyles; P. Ferenci; J. J. Feld; F. Calinas; M. Gschwantler; E. Gane; D. Crawford; I. M. Jacobson; E. O. Dumas; M. King; M. Sulkowski

+ Author Information

Author Information: Johns Hopkins University


		Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


		Loading Related Articles

Time to viral suppression is not related to achievement of SVR12 in HCV GT1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin

Abstract

Related Topics